Page last updated: 2024-08-16

timolol and Hemangioma, Capillary

timolol has been researched along with Hemangioma, Capillary in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	21 (50.00)	24.3611
2020's	21 (50.00)	2.80

Authors

Authors	Studies
Al-Naseem, A; Al-Niaimi, F; Ali, FR; Alzaid, M	1
Alcalá, R; Azaña Defez, JM; Azon, A; Bauzá, A; Bernabeu Wittel, J; Campos-Domínguez, M; Colmenero, M; Del Boz, J; Domínguez-Cruz, J; Feito-Rodríguez, M; García-Doval, I; Garnacho-Saucedo, G; Giacaman, A; González-Enseyat, MA; Grau-Pérez, M; Hernández-Martin, Á; Martín-Santiago, A; Monserrat García, MT; Palencia Pérez, SI; Roé, E; Sánchez Moya, AI; Tercedor-Sánchez, J; Torrelo, A; Valdivielso-Ramos, M; Vera Casaño, Á; Vicente-Villa, MA	1
Chen, C; Shih, MY	1
Aranegui, B; Lopez-Bernal, T	1
Gong, ZC; Li, CX; Li, H; Ling, B; Zhou, YC	1
Hildebrand, GD; Sipkova, Z	1
Ojha, HR; Verma, N	1
Janmohamed, SR	1
Cavalli, R; Chelleri, C; Fossali, EF; Galeone, C; Gelmetti, C; Milani, GP; Monzani, NA	1
Li, H; Lin, Z; Yu, Z; Zhang, B	1
Duell, K; McNab, S	1
Abagge, KT; Mussato, LP; Oliveira de Carvalho, VO; Petterle, RR; Sakai, LSM; Sandri, CO	1
Artzi, O; Bar-Ilan, E; Friedman, O; Koren, A; Mashiah, J; Zur, E	1
Chen, JJ; Guo, XD; Hu, DL; Shu, Q; Wu, XJ; Xu, S; Xuan, XX; Yang, H; Zhang, H	1
Bajaj, MS; Das, D; Raj, SJS	1
Gutermuth, J; Janmohamed, SR; Saerens, J	1
Chang, L; Chang, SJ; Chen, QY; Chen, ZA; Lin, XX; Ma, G; Qiu, YJ; Ying, HR; Zhang, Y	1
Alsumait, A; Blei, F; Bradley, F; Cotton, C; Covelli, I; Fernández Faith, E; Frieden, IJ; Gupta, D; Harfmann, K; Hunt, R; Moore-Clingenpeel, M; Nguyen, H; Pope, E; Shah, S; Streicher, JL; Tollefson, M; Witman, PM	1
Baselga, E; Bernabeu-Wittel, J; Gich, I; Montserrat-García, MT; Muñoz-Garza, FZ; Puig, L; Ríos, M; Roé-Crespo, E	1
Agrawal, S; Bajaj, MS; Das, D; Gupta, S; Modaboyina, S	1
Rodríguez Bandera, AL; Sebaratnam, DF; Wargon, O; Wong, LF	1
Elmazar, HF; Khairy, HA; Mandour, SS; Marey, HM	1
Gummi, R; Marsh, JD; Stahl, ED	1
Arevalo-Rodriguez, I; Baselga, E; Beltran, S; Giraldo, L; Novoa, M; Pardo-Hernandez, H; Shahbaz, A	1
Costa, RD; Prindaville, B; Rork, JF; Wiss, K	1
Drolet, BA; M Hill, I; Stefanko, N	1
Boakye-Agyeman, F; Drolet, BA; Harper, B; Holland, K; Lewandowski, A; Melloni, C; Stefanko, N	1
Hildebrand, GD; Jefferson, RJ	1
Hildebrand, GD; Xue, K	1
Rizvi, SA; Rizvi, SW; Sharma, R; Yusuf, F	1
Kazandjieva, J; Semkova, K	1
Cohen, ER; Landy, DC; Ovadia, SA; Thaller, SR; Yang, EY	1
Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX	1
Fruge, JH; Massengale, WT; Rouhana, HF	1
Hildebrand, GD; Painter, SL	1
Bayart, C; Desai, R; Gill, K; Golden, A; Raimer, P; Tamburro, J	1
Ariwibowo, L; Budiyanto, A; Danarti, R; Radiono, S	1
Guo, S; Ni, N	1
Guo, S; Langer, P; Ni, N; Wagner, R	1
Guo, S; Langer, P; Ni, N	1
Burón, I; Calvo, M; Fueyo-Casado, A; Garcia-Millán, C; Villegas, C	1
Chen, H; Chen, XD; Hu, XJ; Jin, YB; Lin, XX; Ma, G; Qiu, YJ; Ye, XX	1

Reviews

10 review(s) available for timolol and Hemangioma, Capillary

Article	Year
Topical timolol in dermatology: infantile haemangiomas and beyond. Clinical and experimental dermatology, 2022, Volume: 47, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Dermatology; Granuloma, Pyogenic; Hemangioma, Capillary; Humans; Male; Timolol	2022
Letter to the Editor with Reference to "The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials". Dermatology (Basel, Switzerland), 2022, Volume: 238, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome	2022
Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases. Lasers in surgery and medicine, 2020, Volume: 52, Issue:7 Topics: Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Observational Studies as Topic; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2020
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies. British journal of clinical pharmacology, 2020, Volume: 86, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; China; Drug-Related Side Effects and Adverse Reactions; Hemangioma, Capillary; Humans; Propranolol; Timolol	2020
The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta-analysis. International journal of dermatology, 2020, Volume: 59, Issue:11 Topics: Bayes Theorem; Hemangioma, Capillary; Humans; Network Meta-Analysis; Propranolol; Timolol	2020
Infantile hemangioma. Part 2: Management. Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; COVID-19; Hemangioma, Capillary; Humans; Infant; Nevus; Pandemics; Propranolol; SARS-CoV-2; Skin Neoplasms; Timolol; Treatment Outcome	2021
Interventions for infantile haemangiomas of the skin. The Cochrane database of systematic reviews, 2018, 04-18, Volume: 4 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Bleomycin; Child, Preschool; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Methylprednisolone; Photochemotherapy; Prednisolone; Propranolol; Radiotherapy; Randomized Controlled Trials as Topic; Remission Induction; Skin Neoplasms; Timolol	2018
Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Annals of plastic surgery, 2015, Volume: 74, Issue:2 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Injections, Intralesional; Models, Statistical; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015
Beta blocker treatment for infantile hemangiomas. Dermatology online journal, 2015, Jul-15, Volume: 21, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015
Current concepts in the management of periocular infantile (capillary) hemangioma. Current opinion in ophthalmology, 2011, Volume: 22, Issue:5 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Propranolol; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome	2011

Trials

4 trial(s) available for timolol and Hemangioma, Capillary

Article	Year
Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:4 Topics: Administration, Topical; Hemangioma; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Skin Neoplasms; Timolol; Treatment Outcome; Ulcer	2021
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial. JAMA dermatology, 2021, 05-01, Volume: 157, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Double-Blind Method; Drug Administration Schedule; Female; Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Male; Pilot Projects; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2021
Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma. Journal of pediatric ophthalmology and strabismus, 2018, Jan-01, Volume: 55, Issue:1 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Neoplasm Staging; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Propranolol; Retrospective Studies; Time Factors; Timolol; Treatment Outcome	2018
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso	2015

Other Studies

28 other study(ies) available for timolol and Hemangioma, Capillary

Article	Year
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain. Pediatric dermatology, 2022, Volume: 39, Issue:4 Topics: Child; Cross-Sectional Studies; Dermatologists; Hemangioma; Hemangioma, Capillary; Humans; Observer Variation; Pediatrics; Propranolol; Spain; Timolol	2022
RF - FTopical Timolol in Dermatology. Actas dermo-sifiliograficas, 2023, Volume: 114, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Dermatology; Granuloma, Pyogenic; Hemangioma, Capillary; Humans; Timolol	2023
Application of topical betaxolol to cure superficial infantile hemangioma: A pilot study. Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1 Topics: Adrenergic beta-Antagonists; Betaxolol; Child; Hemangioma; Hemangioma, Capillary; Humans; Infant; Pilot Projects; Skin Neoplasms; Timolol; Treatment Outcome	2022
Successful Late Treatment of Orbital Infantile Haemangiomas in Two Teenagers with Topical Transcutaneous Timolol Maleate 0.5% Alone. Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:10 Topics: Administration, Topical; Adolescent; Adrenergic beta-Antagonists; Child; Exophthalmos; Female; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2022
Early management of capillary haemangioma to prevent stimulus-deprivation amblyopia. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2022, Volume: 14, Issue:28 Topics: Amblyopia; Child; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Propranolol; Timolol	2022
Comment on "Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas". Pediatric dermatology, 2019, Volume: 36, Issue:5 Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Timolol	2019
Propranolol and topical timolol for infantile haemangiomas of the skin. Journal of paediatrics and child health, 2020, Volume: 56, Issue:3 Topics: Hemangioma; Hemangioma, Capillary; Humans; Propranolol; Skin; Timolol	2020
Colorimetric analysis of images in the follow-up of infantile hemangiomas. Pediatric dermatology, 2020, Volume: 37, Issue:4 Topics: Adrenergic beta-Antagonists; Colorimetry; Female; Follow-Up Studies; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2020
Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas. Dermatology (Basel, Switzerland), 2020, Volume: 236, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Drug Delivery Systems; Female; Hemangioma, Capillary; Humans; Hyperthermia, Induced; Infant; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol	2020
Acquired sessile conjunctival capillary haemangioma in an adult managed with topical timolol. BMJ case reports, 2020, Aug-24, Volume: 13, Issue:8 Topics: Administration, Topical; Conjunctival Neoplasms; Female; Hemangioma, Capillary; Humans; Timolol; Young Adult	2020
An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma. Pediatric dermatology, 2021, Volume: 38, Issue:1 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Propranolol; Timolol; Treatment Outcome; Vasoconstriction	2021
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma. JAMA dermatology, 2021, 05-01, Volume: 157, Issue:5 Topics: Adrenergic beta-Antagonists; Age Factors; Bandages; Combined Modality Therapy; Female; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Low-Level Light Therapy; Male; Prognosis; Retrospective Studies; Skin Neoplasms; Skin Ulcer; Timolol; Treatment Outcome; Wound Healing	2021
Effectiveness of treatment of acquired capillary haemangioma using timolol. Clinical & experimental optometry, 2022, Volume: 105, Issue:5 Topics: Hemangioma; Hemangioma, Capillary; Humans; Timolol	2022
Topical timolol for an iris hemangioma. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2018, Volume: 22, Issue:2 Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Female; Hemangioma, Capillary; Humans; Infant; Iris Neoplasms; Magnetic Resonance Imaging; Microscopy, Acoustic; Neoplastic Syndromes, Hereditary; Timolol	2018
Response to "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Comment on "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Systemic timolol exposure following topical application to infantile hemangiomas. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Timolol	2020
Topical timolol treatment for periocular infantile haemangioma in the developing world. Tropical doctor, 2019, Volume: 49, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Timolol; Treatment Outcome	2019
Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops. JAMA ophthalmology, 2013, Volume: 131, Issue:9 Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Ophthalmic Solutions; Timolol; Treatment Outcome; Visual Acuity	2013
Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution. Seminars in ophthalmology, 2015, Volume: 30, Issue:1 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Timolol; Treatment Outcome	2015
Rapid complete regression of an early infantile hemangioma with topical timolol gel. International journal of dermatology, 2014, Volume: 53, Issue:2 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Gels; Head and Neck Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Scalp; Skin Neoplasms; Timolol; Treatment Outcome	2014
Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2016, Volume: 20, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Amblyopia; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Orbital Neoplasms; Retrospective Studies; Timolol	2016
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma. Pediatric dermatology, 2016, Volume: 33, Issue:4 Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Apnea; Brimonidine Tartrate; Female; Hemangioma, Capillary; Humans; Hypothermia; Infant; Ophthalmic Solutions; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Skin Neoplasms; Skin Ulcer; Timolol	2016
Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:5 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Female; Gels; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Prospective Studies; Solutions; Timolol; Treatment Outcome	2016
Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:2 Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Retinoscopy; Timolol; Treatment Outcome; Visual Acuity	2010
Topical timolol for periocular hemangioma: report of further study. Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Timolol	2011
Topical timolol for infantile hemangioma of the eyelid. International journal of dermatology, 2013, Volume: 52, Issue:5 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Infant, Newborn; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Timolol	2013
[Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2012, Volume: 28, Issue:3 Topics: Administration, Topical; Angiogenesis Inhibitors; China; Facial Neoplasms; Hemangioma; Hemangioma, Capillary; Humans; Infant; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2012